BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32281514)

  • 1. Simulating the effect of cerebral blood flow changes on regional quantification of [
    Heeman F; Yaqub M; Lopes Alves I; Heurling K; Bullich S; Gispert JD; Boellaard R; Lammertsma AA;
    J Cereb Blood Flow Metab; 2021 Mar; 41(3):579-589. PubMed ID: 32281514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parametric imaging of dual-time window [
    Heeman F; Yaqub M; Hendriks J; Bader I; Barkhof F; Gispert JD; van Berckel BNM; Lopes Alves I; Lammertsma AA
    Neuroimage; 2021 Jul; 234():117953. PubMed ID: 33762215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative 11C-PiB Delivery as a Proxy of Relative CBF: Quantitative Evaluation Using Single-Session 15O-Water and 11C-PiB PET.
    Chen YJ; Rosario BL; Mowrey W; Laymon CM; Lu X; Lopez OL; Klunk WE; Lopresti BJ; Mathis CA; Price JC
    J Nucl Med; 2015 Aug; 56(8):1199-205. PubMed ID: 26045309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of Noninvasive Tracer Kinetic Analysis of
    Bullich S; Barthel H; Koglin N; Becker GA; De Santi S; Jovalekic A; Stephens AW; Sabri O
    J Nucl Med; 2018 Jul; 59(7):1104-1110. PubMed ID: 29175981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized dual-time-window protocols for quantitative [
    Heeman F; Yaqub M; Lopes Alves I; Heurling K; Berkhof J; Gispert JD; Bullich S; Foley C; Lammertsma AA;
    EJNMMI Res; 2019 Mar; 9(1):32. PubMed ID: 30919133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of brain beta-amyloid deposition in transgenic mouse models of Alzheimer's disease with PET imaging agents
    Son HJ; Jeong YJ; Yoon HJ; Lee SY; Choi GE; Park JA; Kim MH; Lee KC; Lee YJ; Kim MK; Cho K; Kang DY
    BMC Neurosci; 2018 Jul; 19(1):45. PubMed ID: 30053803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parametric imaging and quantitative analysis of the PET amyloid ligand [(18)F]flutemetamol.
    Heurling K; Buckley C; Van Laere K; Vandenberghe R; Lubberink M
    Neuroimage; 2015 Nov; 121():184-92. PubMed ID: 26209803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeatability of parametric methods for [
    Verfaillie SC; Golla SS; Timmers T; Tuncel H; van der Weijden CW; Schober P; Schuit RC; van der Flier WM; Windhorst AD; Lammertsma AA; van Berckel BN; Boellaard R
    J Cereb Blood Flow Metab; 2021 Mar; 41(3):569-578. PubMed ID: 32321347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET.
    Brendel M; Delker A; Rötzer C; Böning G; Carlsen J; Cyran C; Mille E; Gildehaus FJ; Cumming P; Baumann K; Steiner H; Haass C; Herms J; Bartenstein P; Rominger A
    Neuroimage; 2014 Jan; 84():843-53. PubMed ID: 24055703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing radiotracers for myelin imaging: a study comparing 18F-florbetaben, 18F-florbetapir, 18F-flutemetamol,11C-MeDAS, and 11C-PiB.
    Auvity S; Tonietto M; Caillé F; Bodini B; Bottlaender M; Tournier N; Kuhnast B; Stankoff B
    Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):490-501. PubMed ID: 31686177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An exploratory efficacy study of the amyloid imaging agent [(18)F]flutemetamol in Japanese Subjects.
    Senda M; Yamamoto Y; Sasaki M; Yamane T; Brooks DJ; Farrar G; McParland B; Heurling K
    Ann Nucl Med; 2015 Jun; 29(5):391-9. PubMed ID: 25874747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concordance in detecting amyloid positivity between
    Cho SH; Choe YS; Kim YJ; Lee B; Kim HJ; Jang H; Kim JP; Jung YH; Kim SJ; Kim BC; Farrar G; Na DL; Moon SH; Seo SW
    Sci Rep; 2020 Nov; 10(1):19576. PubMed ID: 33177593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads.
    Thurfjell L; Lilja J; Lundqvist R; Buckley C; Smith A; Vandenberghe R; Sherwin P
    J Nucl Med; 2014 Oct; 55(10):1623-8. PubMed ID: 25146124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic modelling for the simultaneous assessment of perfusion and
    Papanastasiou G; Rodrigues MA; Wang C; Heurling K; Lucatelli C; Al-Shahi Salman R; Wardlaw JM; van Beek EJR; Thompson G
    Neuroimage; 2021 Jan; 225():117482. PubMed ID: 33157265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology.
    Wolk DA; Grachev ID; Buckley C; Kazi H; Grady MS; Trojanowski JQ; Hamilton RH; Sherwin P; McLain R; Arnold SE
    Arch Neurol; 2011 Nov; 68(11):1398-403. PubMed ID: 21747004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET quantification of 18F-florbetaben binding to β-amyloid deposits in human brains.
    Becker GA; Ichise M; Barthel H; Luthardt J; Patt M; Seese A; Schultze-Mosgau M; Rohde B; Gertz HJ; Reininger C; Sabri O
    J Nucl Med; 2013 May; 54(5):723-31. PubMed ID: 23471310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voxelwise Relationships Between Distribution Volume Ratio and Cerebral Blood Flow: Implications for Analysis of β-Amyloid Images.
    Sojkova J; Goh J; Bilgel M; Landman B; Yang X; Zhou Y; An Y; Beason-Held LL; Kraut MA; Wong DF; Resnick SM
    J Nucl Med; 2015 Jul; 56(7):1042-7. PubMed ID: 25977462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.
    Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Wilking H; Sprycha M; Borg B; Thibblin A; Eriksson J; Sörensen J; Antoni G; Nordberg A; Lubberink M
    J Nucl Med; 2016 Apr; 57(4):574-81. PubMed ID: 26795290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of cerebral blood flow and amyloid load on SUVR bias.
    Heeman F; Yaqub M; Hendriks J; van Berckel BNM; Collij LE; Gray KR; Manber R; Wolz R; Garibotto V; Wimberley C; Ritchie C; Barkhof F; Gispert JD; Vállez García D; Lopes Alves I; Lammertsma AA;
    EJNMMI Res; 2022 May; 12(1):29. PubMed ID: 35553267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of simulated reduced injected dose on the assessment of amyloid PET scans.
    Young P; Heeman F; Axelsson J; Collij LE; Hitzel A; Sanaat A; Niñerola-Baizan A; Perissinotti A; Lubberink M; Frisoni GB; Zaidi H; Barkhof F; Farrar G; Baker S; Gispert JD; Garibotto V; Rieckmann A; Schöll M;
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):734-748. PubMed ID: 37897616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.